Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5901
iShares iBonds 2029 Term High Yield and Income ETF
IBHI
$499M
| $30K | ﹤0.01% |
1,355
+100
| +8% | +$2.22K |
|
5902
KraneShares MSCI China Clean Technology Index ETF
KGRN
$53.9M
| $30K | ﹤0.01% |
1,094
-10,405
| -90% | -$277K |
|
5903
Global X AgTech & Food Innovation ETF
KROP
$9.22M
| $30K | ﹤0.01% |
825
+167
| +25% | +$6.62K |
|
5904
Myriad Genetics
MYGN
$290M
| $30K | ﹤0.01% |
1,269
-7,658
| -86% | -$167K |
|
|
PLYA
5905
DELISTED
Playa Hotels & Resorts
PLYA
| $30K | ﹤0.01% |
3,780
+1,780
| +89% | +$16.1K |
|
5906
Outdoor Holding Co
POWW
$260M
| $30K | ﹤0.01% |
13,805
+4,785
| +53% | +$9.35K |
|
5907
Avita Medical
RCEL
$243M
| $30K | ﹤0.01% |
1,709
+620
| +57% | +$9.1K |
|
5908
Summit Therapeutics
SMMT
$10.6B
| $30K | ﹤0.01% |
12,148
+11,524
| +1,847% | +$21K |
|
|
SPE
5909
Special Opportunities Fund
SPE
$145M
| $30K | ﹤0.01% |
2,838
+357
| +14% | +$3.74K |
|
|
LOGC
5910
DELISTED
ContextLogic
LOGC
| $30K | ﹤0.01% |
4,588
+317
| +7% | +$2.51K |
|
|
PTRA
5911
DELISTED
Proterra Inc. Common Stock
PTRA
| $30K | ﹤0.01% |
24,493
-18,483
| -43% | -$22.7K |
|
5912
Cohen & Co
COHN
$40M
| $29K | ﹤0.01% |
7,097
-4,424
| -38% | -$25.2K |
|
5913
Caesarstone
CSTE
$119M
| $29K | ﹤0.01% |
5,574
-1,856
| -25% | -$8.41K |
|
5914
Viant Technology
DSP
$275M
| $29K | ﹤0.01% |
6,386
+3,050
| +91% | +$13.5K |
|
|
MBCN
5915
DELISTED
Middlefield Banc Corp
MBCN
| $29K | ﹤0.01% |
+1,071
| New | +$28K |
|
|
MESO
5916
Mesoblast
MESO
$2.02B
| $29K | ﹤0.01% |
3,829
| – | – |
|
5917
NN Inc
NNBR
$322M
| $29K | ﹤0.01% |
12,116
-176,643
| -94% | -$268K |
|
5918
Ponce Financial Group
PDLB
$502M
| $29K | ﹤0.01% |
3,254
+3,239
| +21,593% | +$25.3K |
|
5919
PUT
Phillips 66
PSX
$93.2B
| $29K | ﹤0.01% |
300
| – | – |
|
5920
Quantum-Si Incorporated
QSI
$161M
| $29K | ﹤0.01% |
15,861
+10,751
| +210% | +$16.8K |
|
5921
Sutro Biopharma
STRO
$340M
| $29K | ﹤0.01% |
628
+229
| +57% | +$11.4K |
|
5922
Unisys
UIS
$209M
| $29K | ﹤0.01% |
7,174
+3,428
| +92% | +$13.6K |
|
5923
Advantage Solutions
ADV
$420M
| $28K | ﹤0.01% |
480
+149
| +45% | +$6.38K |
|
|
AFMD
5924
DELISTED
Affimed
AFMD
| $28K | ﹤0.01% |
4,631
-2,104
| -31% | -$16.9K |
|
5925
Atomera
ATOM
$219M
| $28K | ﹤0.01% |
3,210
+1,636
| +104% | +$12.9K |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.